How to optimize efficiencies at site-centric clinical trials
The global clinical trials landscape has transformed significantly over the past five years. The Covid-19 pandemic accelerated the rapid adoption…
The global clinical trials landscape has transformed significantly over the past five years. The Covid-19 pandemic accelerated the rapid adoption…
Chronic lymphocytic leukaemia is a slow-growing leukaemia characterised by the accumulation of dysfunctional B lymphocytes, primarily affecting older adults. Its…
The latest ICH guideline, Q14, complements Q2(R2) for the validation of analytical procedures. Revision of Q2(R1) into Q2(R2) aligns its…
Two such tools – electronic patient-reported outcomes (ePRO) and electronic clinical outcomes assessments (eCOA) – are often mentioned together. However,…
Oncology is the most active area in clinical trials globally this year, as more resources than ever are being dedicated…
The pharmaceutical industry is fuelled by data. Huge amounts of information are available from sources as diverse as patient health…
Research from GlobalData shows that the Asia-Pacific (APAC) region was the largest contributor to the global clinical trial landscape from…
In the wake of Russia’s invasion of Ukraine, sponsors are increasingly evaluating other European countries to conduct their clinical trials.…
Abacus Medicine Pharma Services wanted lead generation for their Clinical Trial Solutions (CTS) services. They needed thought leadership content that…
To understand why sub-Saharan Africa can appear a daunting prospect to a contract research organisation (CRO) or sponsor looking to…